Nutex Health (NUTX) Return on Capital Employed (2011 - 2026)

Nutex Health has disclosed Return on Capital Employed across 16 years of filings, most recently posting 36.66% for Q1 2026.

• Return on Capital Employed for Q1 2026 came in at 36.66%, down 429.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 36.66% (down 429.0% YoY), and the FY2025 annual result was 43.82%, up 874.0% from the prior year.
• Return on Capital Employed came in at 36.66% for Q1 2026 at Nutex Health, up from 35.17% in the prior quarter.
• In the past five years, Return on Capital Employed ranged from a high of 63.69% in Q1 2022 to a low of 116.91% in Q2 2023.
• The 5-year median for Return on Capital Employed is 2.68% (2024), against an average of 6.09%.
• Across the five-year window, Return on Capital Employed tumbled 17863 bps in 2023 and jumped 11100 bps in 2024, its largest moves.
• Nutex Health's Return on Capital Employed stood at 107.88% in 2022, then soared by 92 bps to 8.35% in 2023, then soared by 498 bps to 33.26% in 2024, then advanced by 6 bps to 35.17% in 2025, then rose by 4 bps to 36.66% in 2026.
• The last three Return on Capital Employed figures came in at 36.66% (Q1 2026), 35.17% (Q4 2025), and 50.04% (Q3 2025), per Business Quant data.